PharmaShots | Incisive News in 3 Shots

Subscribe Now

First Oral Non-Azole Treatment

Scynexis' Brexafemme (ibrexafungerp tablets) Receives the US FDA's Approval as the First Oral Non-Azole Treatment for Vaginal Yeast Infections

Scynexis' Brexafemme (ibrexafungerp tablets) Receives the US FDA's Approval as the First Oral Non-Azole Treatment for Vaginal Yeas...

June 2, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us